Long term effect of alpha interferon in children with chronic hepatitis B

Gut

Volumn 46, Issue 5, 2000, Pages 715-718

  Bortolotti, F ^a   Iorio, R ^e   Pace, M ^c   Con, P ^a   Gatta, A ^b   Jara, P ^b   Barbera, C ^c   Gregorio, G V ^d   Vegnente, A ^e   Zancan, L ^a   Hierro, L ^b   Crivellaro, C ^f   Vergani, G Mieli ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b HOSPITAL INFANTIL LA PAZ   (Spain)

^c UNIVERSITY OF TURIN   (Italy)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Institute of Semeiotica Medica   (Italy)

Author keywords

Children; Hepatitis B; Hepatitis B virus; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LONG-TERM CARE; MALE; MULTICENTER STUDIES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034023606     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.715     Document Type: Article

References (17)

1. 1 Ruiz Moreno M, Camps T, Garcia Aguado J, et al. A serological and histological follow-up of chronic hepatitis B infection. Arch Dis Child 1989;64:1165-9.
2. 2 Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990;99:805-10.
3. 3 Beasley RP. Hepatitis B virus. The major etiology of hepato-cellular carcinoma. Cancer 1988;6:1942-5.
4. 4 Lai CL, Lin HJ, Lau HJ, et al. Effect of recombinant alpha 2 IFN with or without prednisone in Chinese HBsAg carrier children. QJM 1991;78:155-63.
5. 5 Ruiz Moreno M, Rua MJ, Molina J, et al. Prospective, randomized, controlled trial of IFN alpha in children with chronic hepatitis B. Hepatology 1991;13:1035-9.
6. 6 Barbera C, Bortolotti F, Crivellaro C, et al. Recombinant interferon α 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 1994;20:287-90.
7. 7 Gregorio M, Jara P, Hierro L, et al. Lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B: a multicentre controlled trial. Hepatology 1996;23:700-7.
8. 8 Sokal EM, Conjeevaram H, Roberts EA, et al. Interferon alpha for treatment of pediatric chronic hepatitis B: a randomized controlled multicenter trial. Gastroenterology 1998; 114:988-95.
9. 9 Korenman J, Baker B, Waggoner J, et al. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-34.
10. 10 Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B. New Engl J Med 1996;334:1422-7.
11. 11 Lau DT, Everhart J, Klainer DE, et al. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterolgy 1997;113:1660-7.
12. 12 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
13. 13 De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;2:626-8.
14. 14 Ruiz-Moreno M, Camps T, Jimenez J, et al. Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol 1995;22:540-4.
15. 15 Lau GKK, Lim W, Lock ASF. Nine years follow-up after interferon (IFN) treatment for chronic hepatitis B (CHB) in Chinese patients. Hepatology 1997;26:259A.
16. 16 Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29:184-90.
17. 17 Bortolotti F, Wirth S, Crivellaro C, et al. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. J Pediatr Gastroenterol Nutr 1996;22:270-4.